phox function in a chronic granulomatous disease patient, also perturbed class II Ag presentation and intracellular ROS production. Reconstitution of patient B cells with a wild-type, but not a mutant, p40
phox allele restored exogenous Ag presentation and intracellular ROS generation. Remarkably, class II presentation of epitopes from membrane Ag was robust in p40 phox -deficient B cells. These studies reveal a role for NADPH oxidase and p40 T he phagocyte NADPH oxidase plays a critical role in microbial killing by catalyzing electron transfer from NADPH to molecular oxygen, giving rise to superoxide and other forms of reactive oxygen species (ROS) (1) . This oxidase contains several phox subunits, including gp91 phox and p22 phox , which comprise flavocytochrome b 558 as well as cytoplasmic p40 phox , p47 phox , and p67 phox . The binding of ligands to phagocyte receptors stimulates cytoplasmic subunit translocation to membrane-bound flavocytochrome b 558 , facilitating superoxide production (1) . Phox subunit mutations are associated with chronic granulomatous disease (CGD), characterized by the absence of or marked reduction in ROS production, recurrent pathogenic infections, and granulomatous inflammation (2, 3) .
Whereas the microbicidal role of phagocyte NADPH oxidase during the innate immune response to pathogenic infections is established (2) , its function in APC/T cell interactions is less well understood. In gp91 phox -deficient dendritic cells, but not macrophages, NADPH oxidase tempers phagosome acidification, preserving internalized Ags for efficient MHC class I-mediated cross-presentation to CD8 + T cells (4, 5) . In contrast, CD4 + T cell activation was enhanced in response to murine macrophages with p47 phox mutations (6) . Thus, mutation of distinct oxidase subunits may differentially affect cellular immune responses.
Evidence is conflicting regarding a direct role for NADPH oxidase in regulating MHC class II (MHC II) Ag presentation. Presentation of exogenous OVA but not tetanus toxoid Ag was altered in APCs from CGD patients (7, 8) . Neither study identified the defective oxidase subunits in the CGD patientderived APCs. ROS produced by NADPH oxidase can regulate autophagy in phagocytes (9) , and oxidase subunits are detected in endosomes and phagosomes (10) . Presentation of exogenous Ag via MHC II requires Ag transit and proteolysis in endosomes and lysosomes to yield peptide ligands (11) . Cytoplasmic or nuclear Ag can also access MHC II via several autophagy pathways (12) . MHC II ab complexes are directed via the invariant chain (Ii) to endosomes where proteases fragment Ii (13) . HLA-DM, whose function is regulated by HLA-DO, facilitates the removal of these fragments and antigenic peptide capture by MHC II. The resulting peptide/ MHC II complexes then traffic to the cell surface for immune surveillance by CD4 + T cells. The p40 phox subunit has been associated with Crohn's disease and rheumatoid arthritis in genome-wide association 
Materials and Methods

Cell lines
Human B lymphoblastoid cell lines (B-LCLs) and T cells have been described (17, 18 phox (10) , and glutamate decarboxylase (GAD; SigmaAldrich). The mAb DA6.147 detects HLA-DRa and HLA-DRab dimers (20) . The mAb PIN1.1 detects Ii (21) . Membranes were stripped and reprobed for b-actin (Sigma-Aldrich) or GAPDH (Chemicon) as controls for sample loading. Quantity One one-dimensional analysis software (Bio-Rad) was used to quantify protein expression.
Ag presentation
APCs were incubated with or without 10-20 mM human serum albumin (HSA), human IgG Ag (Sigma-Aldrich), or peptides HSA 64-76 , kI 188-203 , and kII 145-159 (Quality Controlled Biochemicals) for 6 h at 37˚C. APCs were washed and incubated with epitope-specific T cells for 24 h at 37˚C prior to analysis for T cell activation (17) . Data shown are the averages of triplicate samples for each assay, and the error bars indicate the mean T cell activation (6SD). Statistical comparisons between two groups were performed using an unpaired t test, whereas comparison among three groups was performed using a one-way ANOVA. In each case, p # 0.01 was considered to be significant. Adjustment for multiple comparisons was made using the Bonferroni correction.
Flow cytometry and ROS production
Cells were fixed, permeabilized, and incubated with the mAb MaP.DM1 or HLA-DO (BD Biosciences) (17) . To detect intracellular ROS, viable cells were incubated with 5 mM 5-(and-6)-chloromethyl-29,79-dichlorodihydrofluorescein diacetate, acetyl ester (Invitrogen) and stimulated with or without 10 mg/ml PMA (Sigma-Aldrich) for 30 min at 37˚C (22) . Cellular ROS production was sensitive to the oxidase inhibitor diphenyleneiodonium.
Results and Discussion
Diminished cytoplasmic Ag presentation in B-LCLs with reduced p40 phox expression
Autophagy promotes cytoplasmic Ag presentation by MHC II (12, 23) . To test whether p40 phox plays a role in cytoplasmic GAD Ag presentation, p40
phox expression was disrupted in the B cell line PriessGAD using shRNA. Expression of p40 phox was reduced ∼80% in these cells compared with parental PriessGAD, whereas GAD Ag expression was unperturbed (Supplemental Fig. 1A, 1B) . The ability of p40 phox -deficient B-LCLs to present GAD epitopes was substantially reduced (Fig. 1A) . PriessGAD cells transduced with control hb 2 m shRNA (Supplemental Fig. 1C ) stimulated GAD-specific T cells comparably with parental PriessGAD (Fig. 1A) . Levels of LC3-II, a marker of autophagosome formation (24) , were similar in each B cell line tested, suggesting little change in autophagy with disruption of p40 phox (Supplemental Fig.  1D ). Surface expression of HLA-DR4 was equivalent for PriessGAD and shRNA-treated cells (Supplemental Fig. 1E,  1F) . Notably, PriessGAD cells with reduced p40
phox levels stimulated T cells specific for endogenous Ag Igk more efficiently than did the parental PriessGAD cells (Fig. 1B) . These results suggest that reduced p40 phox expression in B-LCLs may compromise cytoplasmic Ag presentation while favoring epitope presentation from endogenous Igk.
Reducing B-LCL p40
phox expression disrupted MHC II exogenous Ag presentation
To evaluate the role of p40 phox in exogenous Ag presentation, p40
phox expression was diminished ∼80% by treating Frev B-LCL with a p40 phox -specific shRNA (Supplemental Fig. 1G ). T cell responses to the exogenous Ag HSA and Frev cells with diminished p40 phox levels were significantly reduced compared with Frev cells transduced with hb 2 m shRNA ( Fig. 2A , Sup- plemental Fig. 1H) 
phox expression to present exogenous IgG Ag was also evaluated. Frev cells with reduced p40
phox levels were less effective in presenting exogenous IgG to T cells compared with Frev transduced with control hb 2 m shRNA (Fig. 2B, 2C ) or the parental line Frev (data not shown). Surface expression of HLA-DR4 was equivalent in each cell line (Supplemental Fig. 1I, 1J ). Only minor differences were observed in exogenous peptide presentation by Frev cells with diminished p40
phox expression compared with cells treated with hb 2 m shRNA ( Fig. 2A-C) . These results suggest that a reduction in p40 phox expression in B-LCLs may perturb multiple routes for Ag presentation by MHC II.
Analysis of the MHC II pathway in B-LCLs with mutations in p40
phox A new genetic subgroup of CGD with mutations in the gene NCF4 encoding p40
phox was described in a patient and linked to functional defects in the neutrophil NADPH oxidase (3). In this patient, one NCF4 allele harbors a frame-shift mutation with a premature stop codon, whereas the other allele encodes a point mutation (R105Q) resulting in a nonfunctional form of p40 phox . A B-LCL from this patient (AR40) expressing HLA-DR4 was further transduced with either WT p40 phox (AR40.DR4.p40 phox WT) or the R105Q mutant allele (AR40.DR4.p40
phox R105Q) to evaluate the effects of p40 phox mutation and reconstitution. Immunoblots demonstrated reduced p40 phox expression in AR40.DR4 cells, consistent with the frame-shifted NCF4 allele as seen in patient neutrophils (3), and higher levels of WT or mutant p40 phox in the reconstituted cells (Fig. 3A) . Levels of gp91 phox and p67 phox were comparably reduced in the reconstituted cells relative to the patient line, likely due to clonal variation. Extracellular ROS production upon PMA stimulation was similar in the patient and WT p40 phox -reconstituted B cells (Supplemental Fig. 2A ) as observed in p40 phox -deficient neutrophils (3). However, basal and PMA-inducible intracellular ROS production were reduced in the AR40.DR4 cells compared with cells expressing WT p40 phox (Fig. 3B) , thus suggesting a defect in the ability of the oxidase in the patient B cells to produce intracellular ROS similar to p40
phox -deficient neutrophils (3) .
Whether the absence of functional p40 phox in AR40.DR4 B-LCLs influenced the expression of molecules in the MHC II Ag presentation pathway was tested. A slight reduction in the levels of total HLA-DRa, HLA-DRab, and Ii were observed in AR40.DR4.p40
phox WT and AR40.DR4.p40
phox R105Q compared with AR40.DR4 (Fig. 3C) . Maturation of Ii was not impaired in AR40.DR4 as detected by the presence of mature glycosylated forms of Ii (Fig. 3C, asterisk) in the p40 phox -deficient and reconstituted B-LCLs. Changes in HLA-DM and HLA-DO can alter Ag presentation without perturbing T cell responses to synthetic peptides (25) (26) (27) . AR40.DR4, AR40.DR4.p40
phox WT, and AR40.DR4. p40
phox R105Q expressed equivalent levels of HLA-DM and HLA-DO (Fig. 3D) . Taken together, these results suggest that the absence of functional p40 phox in AR40.DR4 did not substantially alter the levels of HLA-DR, HLA-DM, HLA-DO, and Ii.
Reconstitution of p40
phox -deficient B-LCLs partially restored MHC II exogenous Ag presentation
Naturally occurring mutations in p40
phox impacted the ability of B-LCLs to efficiently present Ag to MHC II-restricted T cells (Fig. 4) . Reconstitution of the patient-derived AR40. 
DR4 cells with WT p40
phox , but not the mutant p40 phox R105Q allele, enhanced exogenous HSA Ag presentation (Fig. 4A ). AR40.DR4 cells were unable to present either Ig kI or kII epitopes to T cells (Fig. 4B, 4C) . Reconstitution of AR40.DR4 cells with p40 phox WT restored kI epitope presentation to a greater extent than with p40 phox R105Q expression (Fig. 4B) . Only reconstitution of AR40.DR4 with p40
phox WT facilitated presentation of the kII epitope from exogenous human IgG (Fig. 4C) . Although AR40.DR4 cells were able to present exogenously added synthetic peptides to T cells (Fig. 4) , the level of kI peptide presentation was reduced compared with either AR40.DR4.p40
phox WT or AR40.DR4.p40
phox R105Q (Fig. 4B) . Surface expression of HLA-DR4 was equivalent in each cell line (Supplemental Fig.  2B ). Exogenous tetanus toxoid Ag presentation was reduced not only in AR40.DR4 but in B cells deficient in another oxidase subunit, gp91
phox (Supplemental Fig. 2C ), consistent with perturbations in oxidase function modulating MHC II Ag presentation. Reconstitution of AR40.DR4 with WT p40 phox restored tetanus presentation (Supplemental Fig. 2C ). Addition of an extracellular source of ROS failed to reconstitute tetanus presentation by B cells deficient in p40 phox or gp91 phox (Supplemental Fig. 2D ). The ability of AR40.DR4 to endocytose a model exogenous Ag, FITC-albumin, was equivalent for p40
phox -deficient or reconstituted B-LCLs (Supplemental Fig. 2E) . In data not shown, we observed a similar persistence of the FITC-albumin at longer time points (6-18 h) in each cell line. These results suggest that p40 phox deficiency does not substantially affect the internalization or initial degradation of a model exogenous protein.
The presence of assembled HLA-DRab dimers on the surface of AR40.DR4 suggested that these MHC II may acquire peptides from a source other than exogenous Ag. The ability of these cells to present antigenic peptides derived from an endogenous transmembrane protein was evaluated using an HLA-DR4-restricted T cell recognizing an epitope from MHC class I HLA-A. AR40.DR4 cells activated the HLA-Aspecific T cells whereas reconstitution with either the p40 phox WT or R105Q mutant allele did not enhance this Ag presentation (Fig. 4D) . Total MHC class I expression in each of the AR40.DR4-derived cells was equivalent (data not shown). These results suggest that although MHC II-restricted exogenous Ag presentation was impaired in the p40 phox -deficient cells, the presentation of an endogenous transmembrane protein in the context of MHC II could be readily detected.
In conclusion, the microbicidal role of phagocyte NADPH oxidase in neutrophils and macrophages during the innate immune response to pathogenic infections is well established, but the role of the oxidase in APCs during the adaptive immune response is less clear. In this study, functional p40 phox was shown to be required for the efficient presentation of cytoplasmic GAD and multiple exogenous Ags by MHC II in B cells. Additionally, studies suggest that functional gp91 phox is important for MHC II presentation of exogenous Ags. In phagocytes, cytoplasmic p40 phox binds to membrane phosphatidylinositol 3-phosphate (PI3P) and promotes assembly of the NADPH oxidase complex on phagosomes (19) . Association of p40 phox and the oxidase with PI3P found in endosomal/lysosomal membranes (3) could influence MHC II Ag processing and presentation within these organelles. The cytosolic localization of the mutant p40
phox R105Q and lack of PI3P binding (3) may explain its inability to completely restore exogenous Ag presentation in p40 phox -deficient B cells. In B cells, the oxidase may regulate BCR signaling (28) and, as revealed in this study, MHC II Ag presentation. Constitutive and inducible intracellular ROS production was higher in B cells expressing functional p40
phox , supporting a direct role for p40 phox in regulating B cell intracellular ROS generation. Interestingly, p40
phox -deficient B cells were capable of presenting epitopes derived from endogenous membraneresident proteins, suggesting that p40 phox may modulate the peptide repertoire displayed by MHC II on B cells and, subsequently, CD4 + T cell activation. Alterations in the function of the oxidase in B cells may therefore contribute to genetic predisposition to autoimmunity in some CGD patients. Increased incidences of rheumatoid arthritis, inflammatory bowel disease, as well as discoid lupus have been associated with oxidase subunit mutations and CGD (29) .
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